An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment.

Dettagli Bibliografici
Autori principali:	Gelderblom, H, Perol, D, Chevreau, C, Tattersall, M, Stacchiotti, S, Casali, P, Cropet, C, Piperno-Neumann, S, Le Cesne, A, Italiano, A, Ferraresi, V, Duffaud, F, Penel, N, Dileo, P, Bertucci, F, Hassan, A, Kroep, JR, Denizot-Guillemaut, S, Blay, J
Natura:	Journal article
Pubblicazione:	2013

An open-label international multicentric phase II study of nilotinib in progressive pigmented villo-nodular synovitis (PVNS) not amenable to a conservative surgical treatment di Ray-Coquard, I, Gelderblom, H, Chevreau, C, Kroep, JR, Italiano, A, Stacchiotti, S, Le Cesne, A, Piperno-Neumann, S, Ferraresi, V, Duffaud, F, Penel, N, Cassier, P, Tatersall, M, Hassan, A, Nguyen, B, Branchu, V, Guillemaut, S, Cropet, C, Perol, D, Blay, J

Pubblicazione 2012

Conference item